Maglangit, Isaac T.

HRN: 28-68-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2026
CEFTRIAXONE 1G (VIAL)
03/09/2026
03/15/2026
IV
2gm
Q24
Pneumonia
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: